Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A17842 | 27543499 | Br Med Bull | Non-alcoholic fatty liver disease in 2016. | 2016 | Details |
A17843 | 27542533 | Reprod Toxicol | Increased susceptibility of prenatal food restricted offspring to high-fat diet-induced nonalcoholic fatty liver disease is intrauterine programmed. | 2016 | Details |
A17844 | 27541280 | Child Obes | Nonalcoholic Fatty Liver Is Not Associated with the Relationship between Insulin Secretion and Insulin Sensitivity in Obese Children: Matched Case-Control Study. | 2016 | Details |
A17850 | 27532276 | Hepatology | Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. | 2016 | Details |
A17852 | 27527746 | Am J Gastroenterol | Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver. | 2016 | Details |
A17856 | 27522101 | Drug Metab Pers Ther | Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease. | 2016 | Details |
A17864 | 27514759 | Liver Int | Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression. | 2016 | Details |
A17869 | 27513394 | Turk J Med Sci | The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease. | 2016 | Details |
A17878 | 27506737 | Metabolism | Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review. | 2016 | Details |
A17879 | 27506731 | Metabolism | Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view. | 2016 | Details |
A17880 | 27501771 | Br J Nutr | Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects. | 2016 | Details |
A17883 | 27501374 | Expert Opin Emerg Drugs | Promising therapies for treatment of nonalcoholic steatohepatitis. | 2016 | Details |
A17884 | 27500678 | Vopr Kurortol Fizioter Lech Fiz Kult | [The prospects for the application of the natural and preformed therapeutic factors in the treatment of non-alcoholic fatty liver disease]. | 2017 | Details |
A17887 | 27496089 | Eur J Nutr | Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
A17889 | 27494683 | Int Immunopharmacol | High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats. | 2016 | Details |
A17896 | 27493104 | Ann Hepatol |  Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries. | 2017 | Details |
A17899 | 27491150 | Lik Sprava | [PATOGENETIC VALUE OF VIOLATIONS FROM GLUTATHIONE SYSTEM AT THE PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS ON A BACKGROUND OF DIABETES MELLITUS TYPE II]. | 2016 | Details |
A17902 | 27487534 | Wiad Lek | Quality of life in patients with nonalcoholic fatty liver disease in combination with essential hypertension considering taste sensitivity to sodium chloride. | 2018 | Details |
A17908 | 27484357 | Int J Food Sci Nutr | Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection. | 2016 | Details |
A17916 | 27478956 | JAMA Pediatr | Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A17917 | 27477770 | Immunol Lett | The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model. | 2016 | Details |
A17922 | 27475283 | Clin Nutr | Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial. | 2016 | Details |
A17924 | 27474900 | Obesity (Silver Spring) | Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease. | 2016 | Details |
A17925 | 27473796 | Surg Clin North Am | The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2016 | Details |
A17935 | 27468220 | World J Gastroenterol | Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review. | 2016 | Details |
A17941 | 27464726 | Curr Pharm Des | Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines. | 2016 | Details |
A17942 | 27462583 | Ann Pediatr Endocrinol Metab | Ultrasound measurement of pediatric visceral fat thickness: correlations with metabolic and liver profiles. | 2016 | Details |
A17944 | 27459811 | Wei Sheng Yan Jiu | [Change in plasma nesfatin-1 concentration within high-fat diet induced nonalcoholic fatty liver disease rat models]. | 2016 | Details |
A17946 | 27458852 | Turk J Gastroenterol | Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease. | 2016 | Details |
A17950 | 27458255 | Clin Sci (Lond) | Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes. | 2016 | Details |
A17951 | 27458060 | Menopause | Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease. | 2016 | Details |
A17956 | 27455252 | Int J Mol Sci | Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). | 2016 | Details |
A17959 | 27452109 | Antioxid Redox Signal | Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis. | 2016 | Details |
A17960 | 27451965 | J Diabetes Investig | Deoxyribonucleic acid telomere length shortening can predict the incidence of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2016 | Details |
A17970 | 27446224 | Evid Based Complement Alternat Med | The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis. | 2016 | Details |
A17971 | 27445343 | Am J Physiol Gastrointest Liver Physiol | A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats. | 2016 | Details |
A17974 | 27442361 | J Pediatr Endocrinol Metab | Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease. | 2016 | Details |
A17977 | 27439777 | Sci Rep | Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism. | 2016 | Details |
A17983 | 27437098 | Cell Biosci | Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD. | 2016 | Details |
A17986 | 27435856 | Mol Cell Biochem | FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy. | 2016 | Details |
A17988 | 27433943 | Scand J Clin Lab Invest | Serum levels of Lp(a) are related to waist circumference in NAFLD patients with low prevalence of co-morbidities. | 2016 | Details |
A17991 | 27432073 | Best Pract Res Clin Endocrinol Metab | Non-alcoholic fatty liver disease and risk of type 2 diabetes. | 2016 | Details |
A17992 | 27431935 | Int J Mol Med | Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ. | 2016 | Details |
A17997 | 27428080 | Lab Invest | Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation. | 2016 | Details |
A18007 | 27421788 | FASEB J | STK25 is a critical determinant in nonalcoholic steatohepatitis. | 2016 | Details |
A18011 | 27417700 | J Sci Food Agric | Carrot juice ingestion attenuates high fructose-induced circulatory pro-inflammatory mediators in weanling Wistar rats. | 2016 | Details |
A18015 | 27411590 | Cancer Cell | Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma. | 2016 | Details |
A18016 | 27411585 | Cancer Cell | P(URI)fying Novel Drivers of NASH and HCC: A Feedforward Loop of IL17A via White Adipose Tissue. | 2016 | Details |
A18018 | 27411013 | Cell Metab | Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function. | 2016 | Details |
A18020 | 27409822 | Endocr Pract | GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS. | 2016 | Details |
A18023 | 27406999 | Sci Rep | CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications. | 2016 | Details |
A18025 | 27405478 | Surg Endosc | The effects of bariatric surgeries on nonalcoholic fatty liver disease. | 2016 | Details |
A18027 | 27405060 | J Hepatol | Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors. | 2016 | Details |
A18028 | 27404689 | Int J Cardiol | Echocardiography and NAFLD (non-alcoholic fatty liver disease). | 2016 | Details |
A18034 | 27394182 | Clin Chim Acta | Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults. | 2016 | Details |
A18035 | 27393639 | Mech Ageing Dev | Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis. | 2016 | Details |
A18036 | 27393135 | Diabetologia | Effects of exercise training on intrahepatic lipid content in humans. | 2016 | Details |
A18037 | 27393006 | Acta Diabetol | The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population. | 2016 | Details |
A18038 | 27392972 | Obes Surg | Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A18041 | 27391242 | PLoS One | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. | 2016 | Details |
A18049 | 27383530 | J Diabetes Investig | Analysis of risk factors and their interactions in type 2 diabetes mellitus: A cross-sectional survey in Guilin, China. | 2016 | Details |
A18051 | 27382573 | J Diabetes Res | Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients. | 2016 | Details |
A18062 | 27377869 | Clin Exp Immunol | MicroRNA-26a-interleukin (IL)-6-IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model. | 2016 | Details |
A18065 | 27374784 | Stem Cells | Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A18069 | 27372863 | Med Hypotheses | Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance. | 2016 | Details |
A18071 | 27371101 | J Diabetes | Correlations of non-alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults. | 2016 | Details |
A18081 | 27358638 | Afr Health Sci | Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis. | 2016 | Details |
A18082 | 27358174 | Hepatology | Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives. | 2016 | Details |
A18083 | 27357269 | Mol Med Rep | Impact of activating transcription factor 4 signaling on lipogenesis in HepG2 cells. | 2016 | Details |
A18085 | 30695468 | Rinsho Byori | [Progress in the Management of NAFLD/NASH]. | 2016 | Details |
A18088 | 29201749 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease in South Asia. | 2016 | Details |
A18090 | 27355753 | Hepatol Res | Case report of diet-related improvements of non-alcoholic steatohepatitis evaluated by four consecutive liver biopsies. | 2016 | Details |
A18093 | 27353492 | BMC Med | No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. | 2016 | Details |
A18098 | 27352181 | Cell Biochem Biophys | The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid. | 2015 | Details |
A18099 | 27351871 | J Gastroenterol | The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease. | 2016 | Details |
A18104 | 27349927 | Sci Rep | CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis. | 2016 | Details |
A18105 | 27349145 | Eur J Pharmacol | Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
A18109 | 27347998 | Nutrients | Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis. | 2016 | Details |
A18111 | 27347379 | F1000Res | A computer model simulating human glucose absorption and metabolism in health and metabolic disease states. | 2016 | Details |
A18115 | 27345267 | Biochim Biophys Acta Mol Basis Dis | Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration. | 2016 | Details |
A18118 | 27343380 | Eur J Pharmacol | (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation. | 2016 | Details |
A18123 | 27340383 | Immune Netw | The Immune Landscape in Nonalcoholic Steatohepatitis. | 2016 | Details |
A18127 | 27338619 | Glycoconj J | Dicarbonyl stress in clinical obesity. | 2016 | Details |
A18137 | 27325692 | J Biol Chem | XBP1s Is an Anti-lipogenic Protein. | 2016 | Details |
A18138 | 27324703 | J Diabetes Complications | Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome. | 2016 | Details |
A18139 | 27324067 | Metabolism | Nonalcoholic fatty liver disease and obstructive sleep apnea. | 2016 | Details |
A18144 | 27322798 | Ann Intern Med | Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial. | 2016 | Details |
A18145 | 27322467 | EBioMedicine | Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis. | 2016 | Details |
A18149 | 27321334 | Diabetes Res Clin Pract | The impact of body weight gain on nonalcoholic fatty liver disease and metabolic syndrome during earlier and later adulthood. | 2016 | Details |
A18153 | 27317851 | Clin Gastroenterol Hepatol | Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites. | 2016 | Details |
A18154 | 27317790 | Br J Sports Med | Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: a systematic review and meta-analysis. | 2016 | Details |
A18156 | 27315552 | Mol Med Rep | Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet. | 2016 | Details |
A18157 | 27314342 | Int J Mol Sci | A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence. | 2016 | Details |
A18159 | 27313636 | Hepat Mon | The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
A18160 | 27312339 | Sci Rep | Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. | 2016 | Details |
A18167 | 27310544 | Rev Assoc Med Bras (1992) | Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study - sample of São José do Rio Preto. | 2017 | Details |
A18171 | 27309736 | Horm Res Paediatr | Serum Pentraxin 3 Fragment as a Noninvasive Marker of Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2016 | Details |
A18180 | 27307790 | Fibrogenesis Tissue Repair | Activation of hepatic stellate cell in Pten null liver injury model. | 2016 | Details |
A18181 | 27307131 | Phytother Res | Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids. | 2016 | Details |
A18185 | 27304953 | Int J Mol Sci | Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. | 2016 | Details |